NBP
NovaBridge Biosciences. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.83
-0.11 ▼ -3.74%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$2.94
+0.11 ▲ +3.74%
| Index | - | P/E | - | EPS (ttm) | -0.71 | Insider Own | 16.37% | Shs Outstand | 0.12B | Perf Week | -19.14% |
| Market Cap | 0.33B | Forward P/E | - | EPS next Y | -31.82% | Insider Trans | - | Shs Float | 0.10B | Perf Month | -16.52% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.04 | Inst Own | 27.26% | Short Float | 5.75% | Perf Quarter | -30.81% |
| Income | -0.06B | P/S | - | EPS this Y | 8.33% | Inst Trans | 4.07% | Short Ratio | 7.45 | Perf Half Y | -27.44% |
| Sales | 0.00B | P/B | 1.26 | EPS next 5Y | -26.86% | ROA | -17.12% | Short Interest | 5.55M | Perf YTD | -28.89% |
| Book/sh | 2.25 | P/C | 1.43 | EPS past 3/5Y | 47.28% 28.35% | ROE | -22.44% | 52W High | -58.32% ($6.79) | Perf Year | 237.07% |
| Cash/sh | 1.98 | P/FCF | - | Sales past 3/5Y | - | ROIC | -21.67% | 52W Low | 375.63% ($0.60) | Perf 3Y | -24.13% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 72.45% | Gross Margin | - | Volatility(W/M) | 10.58% 8.55% | Perf 5Y | -94.86% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.29 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.47 | EPS Q/Q | -356.44% | Profit Margin | - | RSI (14) | 35.29 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.47 | Sales Q/Q | - | SMA20 | -13.28% ($3.26) | Beta | 1.68 | Target Price | $8 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2025/11/13 | SMA50 | -19.93% ($3.53) | Rel Volume | 0.62 | Prev Close | $2.94 |
| Employees | 32 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 73.2% - | SMA200 | -21.83% ($3.62) | Avg Volume(3M) | 0.74M | Price | $2.83 |
| IPO | 2020/1/17 | Option/Short | Yes/Yes | Trades | 3666 | Volume | 462,255 | Change | -3.74% |
뉴스 로딩 중...